Patents by Inventor Matthew F. Myntti

Matthew F. Myntti has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10827750
    Abstract: A sporicidal composition has a moderately low pH and includes at least one oxidizing acid and the dissociation product of at least one inorganic oxidizing agent. Very high effective solute concentrations can enhance the efficacy of the composition. Embodiments of the composition can be applied to a surface and allowed to absorb into the endospore, ultimately killing at least some of those bacteria in mature endospore form. The surface being treated can be an inanimate surface, particularly a hard surface, or a medical device.
    Type: Grant
    Filed: July 18, 2016
    Date of Patent: November 10, 2020
    Assignee: Next Science IP Holdings Pty Ltd
    Inventor: Matthew F. Myntti
  • Publication number: 20200315956
    Abstract: A biocompatible antimicrobial composition effective against microbial biofilms, including in vivo biofilms containing gram-positive bacteria, can be delivered to and used near the spinal column of vertebrates. Once introduced to an area colonized with a bacterial biofilm, particularly an intervertebral disc, the antimicrobial composition weakens the EPS/ECPS macromolecules of the biofilm, which makes the entire biofilm structure susceptible to being dislodged from the affected area or biosorbed. Additionally or alternatively, certain of the subcomponents of the solute component, as well as perhaps the organic liquid(s) of the solvent component, might lyse microbes, particularly gram-positive bacteria, previously protected by the EPS/ECPS macromolecules. Swelling of and around previously impacted intervertebral discs can be reduced or eliminated, often resulting in appreciable reductions in patient pain levels.
    Type: Application
    Filed: November 16, 2018
    Publication date: October 8, 2020
    Applicant: Next Science IP Holdings Pty Ltd
    Inventor: Matthew F. Myntti
  • Patent number: 10780037
    Abstract: An aqueous composition with a higher-than-neutral pH includes a significant amount of one or more surfactants and large amounts of osmotically active solutes. This composition, as well as an acidic counterpart and solid materials, can be used in a variety of applications such as wound care, oral care, medical equipment reprocessing, healthcare acquired infection and implant treatment.
    Type: Grant
    Filed: January 1, 2019
    Date of Patent: September 22, 2020
    Assignee: Next Science IP Holdings Pty Ltd
    Inventor: Matthew F. Myntti
  • Publication number: 20200260723
    Abstract: A solid material adapted to kill bacteria in planktonic, spore and biofilm states is lethal toward a wide spectrum of gram positive and gram negative bacteria as well as other microbes. The solid material includes a significant amount of one or more surfactants entrained in a crosslinked polymeric network.
    Type: Application
    Filed: April 10, 2020
    Publication date: August 20, 2020
    Inventor: Matthew F. Myntti
  • Patent number: 10653133
    Abstract: A solid material adapted to kill bacteria in planktonic, spore and biofilm states is lethal toward a wide spectrum of gram positive and gram negative bacteria as well as other microbes. The solid material includes a significant amount of one or more surfactants entrained in a crosslinked polymeric network.
    Type: Grant
    Filed: May 10, 2012
    Date of Patent: May 19, 2020
    Assignee: Next Science IP Holdings Pty Ltd
    Inventor: Matthew F. Myntti
  • Publication number: 20200113936
    Abstract: A topical composition can be used to treat or inhibit onset of fibrillar collagenous growths, including but not limited to keloids. The composition includes elemental iodine carried in a non-migratory vehicle. Application of the composition can result in a significant reduction in the size of such a growth or, if applied to an area of skin susceptible to such a growth, inhibit the onset thereof.
    Type: Application
    Filed: June 23, 2018
    Publication date: April 16, 2020
    Applicant: Next Science IP Holdings Pty Ltd
    Inventor: Matthew F. Myntti
  • Publication number: 20200085037
    Abstract: A composition that can solvate biofilms and disrupt bacterial cell walls acts to both kill the bacteria by cell lysis and remove the biofilm. This solvent-containing composition is effective against a broad spectrum of microbes and can be used on a variety of surfaces, both living and inanimate. The polarity of the solvent component of the composition is lower than that of pure water so that the composition exhibits increased efficacy in solvating the macromolecular matrix of a biofilm and in penetrating bacterial cell walls.
    Type: Application
    Filed: November 16, 2019
    Publication date: March 19, 2020
    Applicant: Next Science IP Holdings Pty Ltd
    Inventor: Matthew F. Myntti
  • Publication number: 20200085038
    Abstract: A composition that can solvate biofilms and disrupt bacterial cell walls acts to both kill the bacteria by cell lysis and remove the biofilm. This solvent-containing composition is effective against a broad spectrum of microbes and can be used on a variety of surfaces, both living and inanimate. The polarity of the solvent component of the composition is lower than that of pure water so that the composition exhibits increased efficacy in solvating the macromolecular matrix of a biofilm and in penetrating bacterial cell walls.
    Type: Application
    Filed: November 18, 2019
    Publication date: March 19, 2020
    Applicant: Next Science IP Holdings Pty Ltd
    Inventor: Matthew F. Myntti
  • Patent number: 10441959
    Abstract: A spray head having multiple openings arranged to provide at spray coverage throughout at least 90 degrees from the spray head central axis. The spray head may be used for applying tissue sealants.
    Type: Grant
    Filed: October 28, 2011
    Date of Patent: October 15, 2019
    Assignee: MEDTRONIC XOMED, INC.
    Inventors: Ethan G. Sherman, David J. Little, Wei Chen, John R. Prisco, Matthew J. Friend, Matthew F. Myntti, Tom Zelmer, Cyan Godfrey, Roy Attride
  • Patent number: 10420794
    Abstract: Tissue and other body structures may be protected using a dry, free-flowing, sterilized mixture of chitosan particles and oxidized polysaccharide particles in sealed packaging. The mixture may assist in returning an injured, inflamed or surgically repaired surface to a normal state, e.g., through one or more healing mechanisms such as modulation of an inflammatory response, phagocytosis, mucosal remodeling, reciliation or other full or partial restoration of normal function.
    Type: Grant
    Filed: December 22, 2016
    Date of Patent: September 24, 2019
    Assignee: MEDTRONIC, INC.
    Inventors: Jennifer G. Medina, James Britton Hissong, Matthew F. Myntti, Dana A. Oliver, Brian J. Vaccaro
  • Publication number: 20190262433
    Abstract: A composition that can be used to treat a wide spectrum of gram positive and gram negative bacteria, including but not limited to those in biofilm form, and other microbes can be used in cilia-containing areas such as the sinus cavities and middle/inner ear, while resulting in no, or very minimal amounts of, deciliation. Where such a targeted treatment area includes a biofilm, the composition often can detach and assist in removing the biofilm from affected tissue. Many embodiments of the composition are biocompatible.
    Type: Application
    Filed: June 28, 2017
    Publication date: August 29, 2019
    Inventor: Matthew F. Myntti
  • Publication number: 20190201310
    Abstract: An aqueous composition with a higher-than-neutral pH includes a significant amount of one or more surfactants and large amounts of osmotically active solutes. This composition, as well as an acidic counterpart and solid materials, can be used in a variety of applications such as wound care, oral care, medical equipment reprocessing, healthcare acquired infection and implant treatment.
    Type: Application
    Filed: November 15, 2018
    Publication date: July 4, 2019
    Applicant: Next Science IP Holdings Pty Ltd
    Inventor: Matthew F. Myntti
  • Publication number: 20190191700
    Abstract: An aqueous composition with a higher-than-neutral pH includes a significant amount of one or more surfactants and large amounts of osmotically active solutes. This composition, as well as an acidic counterpart and solid materials, can be used in a variety of applications such as wound care, oral care, medical equipment reprocessing, healthcare acquired infection and implant treatment.
    Type: Application
    Filed: January 1, 2019
    Publication date: June 27, 2019
    Inventor: Matthew F. Myntti
  • Patent number: 10279072
    Abstract: Body tissue and structures in an airway may be treated with an artificial scab comprising an inhomogeneous, uncohesive, solid sheet-like body comprising a granular mixture of chitosan and polysaccharide particles. The artificial scab breaks apart into smaller pieces if peeled away from the surgical site or wound, thus reducing the risk of airway occlusion.
    Type: Grant
    Filed: July 10, 2017
    Date of Patent: May 7, 2019
    Assignee: Medtronic, Inc.
    Inventors: James B. Hissong, Matthew F. Myntti, Jennifer G. Medina
  • Publication number: 20190014777
    Abstract: A sporicidal composition has a moderately low pH and includes at least one oxidizing acid and the dissociation product of at least one inorganic oxidizing agent. Very high effective solute concentrations can enhance the efficacy of the composition. Embodiments of the composition can be applied to a surface and allowed to absorb into the endospore, ultimately killing at least some of those bacteria in mature endospore form. The surface being treated can be an inanimate surface, particularly a hard surface, or a medical device.
    Type: Application
    Filed: July 18, 2016
    Publication date: January 17, 2019
    Applicant: Next Science IP Holdings Pty Ltd
    Inventor: Matthew F. Myntti
  • Publication number: 20170304487
    Abstract: Body tissue and structures in an airway may be treated with an artificial scab comprising an inhomogeneous, uncohesive, solid sheet-like body comprising a granular mixture of chitosan and polysaccharide particles. The artificial scab breaks apart into smaller pieces if peeled away from the surgical site or wound, thus reducing the risk of airway occlusion.
    Type: Application
    Filed: July 10, 2017
    Publication date: October 26, 2017
    Inventors: James B. Hissong, Matthew F. Myntti, Jennifer G. Medina
  • Patent number: 9700648
    Abstract: Body tissue and structures in an airway may be treated with an artificial scab comprising an inhomogeneous, uncohesive, solid sheet-like body comprising a granular mixture of chitosan and polysaccharide particles. The artificial scab breaks apart into smaller pieces if peeled away from the surgical site or wound, thus reducing the risk of airway occlusion.
    Type: Grant
    Filed: October 26, 2011
    Date of Patent: July 11, 2017
    Assignee: Medtronic, Inc.
    Inventors: James Britton Hissong, Matthew F. Myntti, Jennifer G. Medina
  • Patent number: 9700344
    Abstract: Chronic wounds may be treated by debriding necrotic and other devitalized tissue from the wound, and applying to the wound an extracellular polymeric substance solvating system comprising a metal ion sequestering agent, surfactant and buffering agent. The solvating system disrupts biofilms which may be present in the wound and aids or enables the resumption of normal healing.
    Type: Grant
    Filed: June 25, 2014
    Date of Patent: July 11, 2017
    Assignee: MEDTRONIC XOMED, INC.
    Inventors: Matthew F. Myntti, Dana A. Oliver, James B. Hissong, Jennifer G. Medina
  • Publication number: 20170100427
    Abstract: Tissue and other body structures may be protected using a dry, free-flowing, sterilized mixture of chitosan particles and oxidized polysaccharide particles in sealed packaging. The mixture may assist in returning an injured, inflamed or surgically repaired surface to a normal state, e.g., through one or more healing mechanisms such as modulation of an inflammatory response, phagocytosis, mucosal remodeling, reciliation or other full or partial restoration of normal function.
    Type: Application
    Filed: December 22, 2016
    Publication date: April 13, 2017
    Inventors: Jennifer G. Medina, James Britton Hissong, Matthew F. Myntti, Dana A. Oliver, Brian J. Vaccaro
  • Patent number: 9561248
    Abstract: Tissue and other body structures may be protected using a hydrated composition made from free-flowing substantially collagen-free rehydratable polysaccharide particles and rehydratable polysaccharide sponges. Rehydration of the particles without clumping may be carried out be dispersing the particles in a biocompatible water-miscible polar dispersant such as ethanol and combining the dispersion with sufficient aqueous solvent for the particles to convert them to a cohesive hydrogel. The hydrated composition may assist in returning an injured, inflamed or surgically repaired surface to a normal state, e.g., through one or more healing mechanisms such as modulation of an inflammatory response, phagocytosis, mucosal remodeling, reciliation or other full or partial restoration of normal function.
    Type: Grant
    Filed: July 7, 2014
    Date of Patent: February 7, 2017
    Assignee: Medtronic, Inc.
    Inventors: Matthew F. Myntti, Dana A. Oliver, Brian J. Vaccaro